vaccine

News

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

A US government agency is to give a further $472 million to biotech Moderna, after it announced plans to expand a phase 3 trial for its potential COVID-19 jab.

News

Blood sample with respiratory coronavirus positive

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

The UK has secured 90 million doses of two different COVID-19 vaccines from BioNTech/Pfizer and Valneva, with an option of 40 million doses if they check out in trials.

News

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Press reports suggest that there is good news about AstraZeneca and Oxford University’s COVID-19 vaccine due from an early stage trial in the coming days – but the focus is moving on how to

News

Merck & Co's CEO has doubts over fast COVID-19 vaccine devel...

Merck & Co’s CEO Kenneth Frazier has warned that the many COVID-19 vaccines under development are not guaranteed to work, adding that it may be too optimistic to expect one to be approv

News

FDA to fast track development of two COVID-19 vaccines from ...

Two of Pfizer and BioNTech’s potential COVID-19 vaccines have been granted Fast Track status by the FDA, a process designed to hasten their development and review.

News

GSK begins COVID-19 vaccine trial with Clover

GlaxoSmithKline has begun a COVID-19 clinical trial with China’s Clover Biopharmaceuticals, combining its booster with the biotech’s early-stage vaccine.

Moderna gets further $472m as expanded phase 3 COVID-19 tria...

UK announces COVID-19 vaccine deals with BioNTech/Pfizer and...

Call for COVID-19 'challenge trial' ahead of AstraZeneca vac...

Merck & Co's CEO has doubts over fast COVID-19 vaccine devel...

FDA to fast track development of two COVID-19 vaccines from ...

GSK begins COVID-19 vaccine trial with Clover

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

vaccine

Editor's Picks